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The studies presented here demonstrate the protective effect of acetyl-L-carnitine (ALC) against alcohol-
induced oxidative neuroinflammation, neuronal degeneration, and impaired neurotransmission. Our
findings reveal the cellular and biochemical mechanisms of alcohol-induced oxidative damage in various
types of brain cells. Chronic ethanol administration to mice caused an increase in inducible nitric oxide
synthase (iNOS) and 3-nitrotyrosine adduct formation in frontal cortical neurons but not in astrocytes from
brains of these animals. Interestingly, alcohol administration caused a rather selective activation of NADPH
oxidase (NOX), which, in turn, enhanced levels of reactive oxygen species (ROS) and 4-hydroxynonenal, but
these were predominantly localized in astrocytes and microglia. Oxidative damage in glial cells was
accompanied by their pronounced activation (astrogliosis) and coincident neuronal loss, suggesting that
inflammation in glial cells caused neuronal degeneration. Immunohistochemistry studies indicated that
alcohol consumption induced different oxidative mediators in different brain cell types. Thus, nitric oxide
was mostly detected in iNOS-expressing neurons, whereas ROS were predominantly generated in NOX-
expressing glial cells after alcohol ingestion. Assessment of neuronal activity in ex vivo frontal cortical brain
tissue slices from ethanol-fed mice showed a reduction in long-term potentiation synaptic transmission
compared with slices from controls. Coadministration of ALC with alcohol showed a significant reduction in
oxidative damage and neuronal loss and a restoration of synaptic neurotransmission in this brain region,
suggesting that ALC protects brain cells from ethanol-induced oxidative injury. These findings suggest the
potential clinical utility of ALC as a neuroprotective agent that prevents alcohol-induced brain damage and
development of neurological disorders.
Published by Elsevier Inc.
Evidence indicates that millions of chronic alcohol abusers exhibit
neuronal injury and neurocognitive deficits associated with neuronal
degeneration [1–3]. Although oxidative damage has been implicated in
many neurological diseases such as Alzheimer disease, Parkinson
disease, amyotrophic lateral sclerosis, and stroke [4,5], the underlying
mechanisms of alcohol-induced neuropathology remain elusive. There
are multiple mechanisms of alcohol-induced neurotoxicity and neuro-
nal degeneration in various brain regions [6]. Thus, ethanol-elicited
reactive gliosis in hippocampus and cortex clearly indicate the role of
free radical formation in young andaged rats [7]. Findings byPierce et al.
[8] do not support the role of robust oxidative mechanisms as the
primary cause of Purkinje cell death in the cerebella of neonatal rats.
However, other findings indicate that microglial activation, enhanced
neuroinflammation, and oxidative damage occur before brain atrophy
after chronic alcohol ingestion [9,10]. These findings support the notion
that oxidant generation is a cause of neuroinflammation and neuronal
degeneration in alcoholics. Recent findings in postmortem alcoholic
human brain tissues [11] and in animal models [9,12] also indicate that
alcohol-induced astrogliosis causes neuroinflammation.
Recently, Crews and Nixon [13] demonstrated the mechanisms of
alcohol-induced oxidative stress and proinflammatory protein pro-
ducts that trigger neurodegeneration during alcohol intoxication.
Furthermore, Sullivan and Zahr [14] extensively described neuro-
pathological, neuroelectrophysiological, neuropsychological, and neu-
roradiological evidence for alcohol-induced neuronal loss in humans.
We and others have demonstrated the biochemical and molecular
mechanisms of alcohol-induced oxidative production as contributing
factors to neuronal degeneration after alcohol-induced breaching of
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brain microvascular endothelial cells [15,16], brain astrocytes [17,18],
and cultured microglia [19]. We reported a significant induction of
cytochrome P450-2E1 activity, which was associated with increased
levels of reactive oxygen species (ROS) and nitric oxide (NO)
production in human neurons after exposure to 17.5 mM ethanol
(EtOH) [17]. These findings indicate that ethanol metabolism and
subsequent reactive oxidant production by both NADPH oxidase
(NOX) and inducible nitric oxide synthase (iNOS) significantly
contribute to oxidative stress in the central nervous system (CNS).
In biological systems, products of oxidative reactions are broadly
classified as ROS. Major forms of ROS include superoxide anion (O2•−),
hydroxyl radical (•OH), hydrogen peroxide (H2O2), hypochlorous acid,
and alkoxyl and peroxyl radicals. Reactive nitrogen species (RNS)
include the nitric oxide radical and peroxynitrite. ROS (O2•− and •OH)
are produced by normal mitochondrial oxidative phosphorylation, by
conversion of l-arginine to l-citrulline catalyzed by NOX/xanthine
oxidase, and from nonenzymatic Fenton–Haber–Weiss reactions of
H2O2 that occur during reduction of iron. Conversion of l-arginine to l-
citrulline, when catalyzed by calcium/calmodulin-independent iNOS
and -dependent eNOS (endothelial, constitutive) or nNOS (neuronal,
constitutive), produces the short-lived NO. Nitric oxide reacts with
superoxide to form the highly reactive radical peroxynitrite. This RNS
can covalently conjugate with reactive amino acids (e.g., tyrosine) in
proteins and alter their biological properties.
In this study, we investigated the therapeutic efficacy of acetyl-L-
carnitine (ALC) administration in a mouse model of chronic alcohol
feeding. We postulated that administration of ALC would restore
antioxidant levels and improve mitochondrial function, neurotrans-
mission, and neuronal survival in the brains of ethanol-fed mice. ALC
is a naturally occurring neuroprotective agent that delivers carnitine
and acetyl groups in clinical therapeutic settings, currently used for
treatment of strokes and Alzheimer disease [20,21]. ALC acts as the
transporter of long-chain fatty acid (FA) into, and small/medium-
chain FA out of, mitochondria. It is an effective antioxidant and
neurotransmitter and a potent inhibitor of excitotoxicity. ALC is
expected to maintain the normal coenzyme A (CoQ10) level and
oxidative phosphorylation balance within mitochondria. CoQ10 itself
is a neuroprotective agent and antioxidant, found predominantly in
mitochondria, where it maintains and stabilizes the mitochondrial
membrane potential under conditions of oxidative stress. Adminis-
tration of ALC mitigates the age-related decay of mitochondrial
function [22] and increases choline acetyltransferase activity (cholin-
ergic neuronal activity) in rat hippocampus [23]. We hypothesized
that ALC administration in our animal model would improve
neurotransmission and neuronal survival by suppressing generation
of biological oxidants thereby stabilizing dopaminergic and choliner-
gic neurons in the brain. Our findings indeed demonstrate therapeutic
benefits of ALC in preventing alcohol-induced neurodegeneration, the
results of which are reported here.
Materials and methods
Animal procedures
To evaluate the effects of chronic feeding of ethanol liquid diets in
a mouse model, 5-week-old C57BL/6 J male mice were purchased
from The Jackson Laboratory (Bar Harbor, ME, USA) andmaintained in
the University of Nebraska Medical Center animal facility, following
the NIH Guide for the Care and Use of Laboratory Animals. Five days
before actual pair-feeding, all mice were fed the control liquid diet for
2 days and then alcohol-diet-fed mice were acclimated to 28% EtOH
(4% vol/vol, or 870 mM) liquid diet (as percentage of total calories)
for 3 days. Animals were then pair-fed the control or the ethanol
liquid diet for 8 weeks (pair-feeding was based on ethanol diet
consumption) in the following groups: pair-fed control, EtOH-fed,
pair-fed EtOH + ALC, pair-fed EtOH + CoQ10, and pair-fed ALC alone
(eight mice/group, or three mice/basal control of ALC or CoQ10). The
macronutrient composition of the control Lieber–DeCarli diet from
Dyets, Inc., in percentage of total calories is 47% carbohydrate, 35% fat,
and 18% protein, whereas the EtOH liquid diet is 35% fat, 18% protein,
19% carbohydrate, and 28% ethanol. ALC was mixed in liquid diets
(2 mg/ml), whereas CoQ10 (2 mg/g body wt) was administered in
saline solution by daily intraperitoneal (ip) injection. After 8 weeks,
the mice were euthanized by ip injection of ketamine (800 mg/kg).
Blood was removed from all mice for determination of alcohol levels
(determined by EtOH assay kit; Diagnostic Chemicals Ltd, Charlotte-
town, PEI, Canada). Whole-brain tissue weights were recorded before
dissecting into frontal or caudal (without cerebellum) cortical regions
for histopathology. Brains were fixed in 4% paraformaldehyde and
preserved in OCT for immunohistochemistry. Tissues were stored at
−80 °C for protein or RNA extraction.
Western blot
Protein extracts from brain frontal cortex homogenates were
centrifuged at 12,000 rpm for 20 min. Supernatants were diluted in
sample buffer, heated at 95 °C for 3–5 min, and subjected to denaturing
(SDS) electrophoresis by loading 20 μg protein/lane on precast 4–15%
gradient polyacrylamide gels.Molecular-size-separated proteins on gels
were transferred onto nitrocellulose membranes at room temperature
for 1 h at 60 V. After being blocked with Superblock T-20 (Thermo
Scientific, Rockford, IL, USA) containing 2% nonfat dry milk, membranes
were incubated overnightwith primary antibody against iNOS (ab3523,
1:1000), 3-nitrotyrosine (3-NT; ab52309, 1:1000), NOX1 (ab55831,
1:200) (Abcam, Cambridge, MA, USA); 4-hydroxynonenal (4-HNE;
1:1000; HNE11-S, Alpha Diagnostic, San Antonio, TX, USA); or α-actin
(1:1000; Millipore, Billerica, MA, USA) protein at 4 °C followed by 1 h
incubation with horseradish peroxidase-conjugated secondary antibo-
dies at room temperature. The negative controls such as blocking
reagent and secondary antibodywere used to check the specificity of the
immunoblot. Immunoreactive bands were detected by West Pico
chemiluminescence substrate (Thermo Scientific) using the autoradi-
ography developer. Data were quantified as arbitrary densitometry
intensity units using theGelpro32 software package (version 3.1;Media
Cybernetics, Marlow, UK).
Immunofluorescence and microscopy
Immunohistochemistry was performed on 5-μm brain tissue
coronal sections. Tissue sections were washed with phosphate-
buffered saline (PBS) and fixed in acetone and methanol (1/1 vol/
vol) and were blocked at room temperature in PBS containing
blocking serum (3% bovine serum albumin; BSA). Tissues were then
incubated with respective primary antibodies (Abcam) such as 3-NT
(ab61392, ab78406, 1:200), iNOS (ab3523, 1:50), NOX1 (ab55831,
1:150), tyrosine hydroxylase (TH; ab113, 1:1000), or choline
acetyltransferase (ChAT; ab18736, 1:1000) with 0.4% Triton X-100
overnight at 4 °C. Antibodies to NeuN (ab77315; 1:250), neurofila-
ments (ab28029; 1:100), GFAP (ab7260, ab10062, 1:250), and Iba1
(ab5076, 1:100) were used for detection of neuronal nucleus and
cytoplasm, neurofilaments, astrocytes, and microglia, respectively, in
brain tissue sections. After being washed with PBS, tissue sections
were incubated with the secondary antibody (Alexa Fluor 488 and
Alexa Fluor 594; Invitrogen; 1:500) for 1 h. Blocking sera (BSA)
without primary/secondary antibodies and secondary antibody
without primary antibody were used as negative controls to detect
the specificity of immunofluorescence. Immunohistochemical studies
for all marker proteins were mounted in Immunomount containing
DAPI to stain nuclei (Invitrogen). Tissue sections were analyzed by
fluorescence microscope (Eclipse TE2000-U; Nikon, Melville, NY,
USA) connected to a color DigFire digital camera (Photometrics Cool
Snap EZ, Goleta, CA, USA).
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ROS detection
Brain tissues from the various treatment conditions were washed in
KDD buffer and cut into pieces with nonmetallic (plastic) scalpel, and
tissues (100 mg/tube) were suspended in spin-probe solution for
detection of ROS and RNS. Tissues were totally submerged in the spin-
probe solution (1.0 ml) in Eppendorf tubes before incubation at37 °C for
30–60 min. Samples aspirated in a 1.0-ml syringe were snap-frozen in
liquid nitrogen until detection of ROS by electron paramagnetic
resonance (EPR; Bruker Escan E-box tabletop model, Serial 0264)
within 1 h. The EPR was set at field sweep in lagtime that read 10×10
scans for an accumulative, or a "time course" protocol: microwave
bridge → attenuator 4.0 for liquid samples, 17 for frozen samples;
number of scans per sample 10; hall→ center field 3450.189 Gauss (G),
sweep width 60 G, static field 3451.189 G. Krebs Hepes buffer contains
99 mM NaCl, 4.69 mM KCl, 2.5 mM CaCl2·2H2O, 1.2 mMMgSO4·7H2O,
25 mM NaHCO3, 1.03 mM KH2PO4, 5.6 mM d-(+)-glucose, and 20mM
Na-Hepes. KDD buffer consists of the Krebs Hepes buffer and the
chelatorsDF (25 μM)andDETC (5 μM).Weused the spin-probe solution
CMH (Noxygen, NOX-2.3–100mg; Axxora ALX-430-117-M010) in KDD
buffer,which reactedwith intracellular superoxide. The nonspecific free
radical measurementwas corrected by subtracting the arbitrary units of
10 mM specific scavenged condition, such as mannitol (Sigma M9647,
Sigma B3420) for hydroxyl radicals, superoxide dismutase (Sigma
G001835) for superoxide, and cPTIO (Sigma C221) for nitric oxide, from
the unscavenged experimental conditions. Data are presented as
cumulative detection of both the hydroxyl and the superoxide free
radicals. TEMPOL and H2O2 were used as positive controls for the
presence of free radicals.
Electrophysiology recordings
We then studied the long-term potentiation (LTP) synaptic
transmission of neuronal activity in ex vivo frontal cortical brain
tissue slices by electrophysiology. Briefly, three mice each from
control, EtOH, and EtOH + ALC as described above were used for
electrophysiological recordings at week 7 to 8. Brains removed from
the cranial cavity were placed into ice-cold (4 °C) preoxygenated
artificial cerebrospinal fluid (ACSF). Frontal cortex transverse ex vivo
brain slices (400 μm in thickness) were prepared using a tissue
chopper after a previously published method [24]. Slices were kept in
a humidified/oxygenated holding chamber at room temperature for
at least 1 h before being transferred to a recording chamber. In the
recording chamber, a single frontal cortex slice was submerged and
perfused continuously (2.0 ml/min) with ACSF containing 124 mM
NaCl, 3 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 1 mM NaH2PO3, 26 mM
NaHCO3, and 10 mM glucose equilibrated with 95% O2 and 5% CO2, pH
7.35–7.45. The perfusate temperature was maintained at 30±1 °C
with an automatic temperature controller (Warner Instrument Corp.,
Hamden, CT, USA).
Field excitatory postsynaptic potentials (fEPSPs) were elicited by a
constant current stimulation (0.05 Hz, 100–300 μA, test pulses) of
Schaffer collateral-commissural axons using an insulated bipolar
tungsten electrode. Intensity and duration of stimulation were
adjusted to generate approximately 50% of the maximal response.
Evoked fEPSPs were recorded with an Axopatch-1D amplifier
(Molecular Devices, Sunnyvale, CA, USA) in the CA1 dendrite field
(stratum radium). Recordings were made with borosilicated glass
microelectrodes with a tip diameter of 2.5–5.0 μm and a resistance of
1–5 MΩ when filled with ACSF. A 15- to 20-min control (baseline)
recording was conducted in each experiment once the adjustment of
stimulation parameters was achieved. Electrical signals were filtered
at 1 kHz and digitized at a frequency of 2.5 kHz using a Digidata 1320
interface (Molecular Devices). Data were stored on a desktop PC and
analyzed offline using pCLAMP 10 software (Molecular Devices).
Initial slope of the EPSPs was expressed as percentage of basal level,
which is the average of the initial slopes of the first 5 min.
Statistical analysis
Results are expressed as mean values (±SD), and a probability
value of≤0.05 was considered significant. Statistical significance was
assessed by two-way ANOVA analyses with Newman–Keuls posttest
for multiple comparisons.
Results
The average body weight of ethanol-fed mice was significantly
higher (pb0.02; N=8) than that of pair-fed controls or mice in the
Table 1
Body and brain weights and blood alcohol levels in alcohol-fed mice
Condition Body weight
(g)
Brain weight
(g)
Brain weight
expressed in
mg/g body wt
Blood alcohol
level (mM)
Control 22.78±2 0.427±0.01 19.0 0.0±0.003
EtOH 24.47±2 0.404±0.02 16.5 17.6±3.77
EtOH + ALC 22.88±2 0.413±0.01 18.0 10.8±2.05
EtOH + CoQ10 23.73±2 0.402±0.01 17.0 10.2±1.75
ALC 24.89±2 0.414±0.02 16.6 0.0±0.002
Fig. 1. ALC prevented alcohol-induced reduction in LTP synaptic transmission in frontal
cortex tissue slice. LTP synaptic responses were induced by a constant current
stimulation (twin pulses, 150–300 μA, 40 μs, 0.05 Hz) of Schafer collateral fibers in
three conditions. The graphs plot the initial slope of the first evoked excitatory
postsynaptic potentials recorded from the frontal cortex in response to constant current
stimuli. Synaptic transmission in the frontal cortex region of mouse brain slices is
shown. (A) Input and output curves. (B) Pair-fed control mice, EtOH liquid diet, EtOH
liquid diet with ALC supplementation. Results are expressed as mean values of three
mice per group (±SD; n=3).
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alcohol+ALCgroup. Conversely, themeanweightofwhole-brain tissue
of alcohol-fed mice was lower than that of the control or alcohol + ALC
group after 8 weeks of liquid diet administration (see Table 1). The
average amount of intake per animal was about 17.0 ml during the
control liquid diet acclimation period. The pattern of food intake during
pair-feeding was about 12, 15, 16, and 18ml/mouse, respectively, at
week 1, 2, 3, and 4–8. Pair-feeding of all other conditions was based on
the volume of EtOH liquid diet intake in the alcohol condition.
Alcohol-fed animals exhibitedbehavioral changesduring theethanol
period. We observed that these animals were physically less active and
were less alert compared with the pair-fed control or the alcohol-diet
plusALCanimals.We speculated that the change inbehaviorwas related
to impairment of synaptic transmission resulting from alcohol-induced
oxidative damage andmitochondrial energy depletion, leading to loss of
neuronal activity. Thus, we analyzed the low-frequency stimulus (LFS)
and LTP synaptic transmission of neuronal activity in ex vivo frontal
cortical brain tissue slices. These analyses revealed a significant
reduction in LTP and LFS synaptic transmission in the CA1 region in
brain slices from alcohol-fed mice compared with pair-fed controls
(Figs. 1A and B). As anticipated, ALC prevented the alcohol-elicited loss
of LTP and LFS synaptic transmission in the frontal cortex, suggesting
that ALC blocked the loss of neuronal activity, perhaps by stabilizing
mitochondrial function. These data are consistent with our recent
findings that, in culture, ALC exposure protects primary human neurons
from EtOH/Acetaldehyde (Ach) insult [17].
To evaluate the neuroprotective effects of ALC in our animalmodel,
we first examined the changes in the expression of neuronal marker
protein neurofilament (NF) in frontal cortex coronal sections by
immunofluorescence, using antibody to neurofilament protein. The
data indicated that ethanol administration diminished NF fluores-
cence in cortical sections. However, daily coadministration of ALC
with ethanol liquid diet prevented the loss of NF from cortical neurons
in these animals (Figs. 2A–C). The mitochondrial-specific antioxidant
CoQ10 afforded very minimal neuroprotection from chronic alcohol
administration (data not shown), similar to our unpublished data in
cell culture studies, which was attributed to the impermeability of
exogenous CoQ10 across the cellular and mitochondrial membranes.
Thus, we focused here on the protective effects of ALC, rather than
that of CoQ10, from alcohol insult. Because the integrity of the
neurofilaments was affected by alcohol ingestion, we determined the
susceptibility of specific types of neurons to chronic alcohol in take.
Here, we identified the loss of dopaminergic neurons by loss of
fluorescence in TH protein and cholinergic neurons by the loss of
fluorescence in ChAT in coronal sections of the brain. Our findings
Fig. 2. ALC administration protected frontal cortical neurons from depletion of NF from chronic alcohol feeding. (A–C) Immunohistochemical staining for marker protein
(neurofilaments, NF) on 5-μm tissue sections from (A) control, (B) EtOH, and (C) EtOH+ALC conditions. Neurofilaments were immunolabeled with antibody to NF (mouse IgG,
1:100; Abcam ab28029) for 1 h at 24 °C. Alexa Fluor 488 anti-mouse secondary antibody was used for conjugation and fluorescence detection of neurofilaments (green). (D–F)
Expression of dopaminergic neuronal marker protein tyrosine hydroxylase (TH, green) in (D) control, (E) EtOH, and (F) EtOH + ALC. (G–I) Cholinergic neuronal marker protein
choline acetyltransferase (ChAT, green) in (H) control, (I) EtOH, and (J) EtOH+ALC. TH (sheep IgG, 1:1000; Abcam ab113) and ChAT (sheep IgG, 1:1000, Abcam ab18736) were used
as primary antibodies for these stainings. Alexa Fluor 488 anti-sheep secondary antibody was used for both TH and ChAT. Original magnification, ×20.
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revealed that dopaminergic neurons, mostly localized in the sub-
stantia nigra region, exhibited degeneration after ethanol adminis-
tration (Figs. 2D–F). Similarly, cholinergic neurons detected in the
outer region of the brain striatum in ethanol-fed mice were less
distinct comparedwith control and ALC+ EtOH-fedmice (Figs. 2G–I).
Coadministration of ALC seemed to protect both dopaminergic and
cholinergic neurons from alcohol insults in this region.
In agreement with our recent in vitro findings, we observed a
twofold increase in the intensity of the 135-kDa iNOS protein in the
frontal cortex after chronic alcohol ingestion compared with controls
(Fig. 3A). Immunohistochemistry and confocal microscopy studies
showed distinctive staining of neurofilaments around iNOS in the
cytoplasm of neurons, particularly in brain tissues from alcohol
ingestion (Fig. 3B). Coadministration of ALC with ethanol for 8 weeks
significantly decreased alcohol-elicited iNOS protein induction in this
brain region (Figs. 3A and B). Because the staining for neurofilaments
and iNOS was localized differentially within the same cell body, we
further confirmed the localization of iNOS in neurons by colocalizing
with NeuN protein. Antibody to NeuN is specific to the nucleus and
cytoplasm of neurons only, and our results clearly provide the evidence
Fig. 3. Alcohol-induced iNOS protein colocalizedwith neurofilaments in brain frontal cortex. Protein extracts derived from the frontal cortexwere analyzed for alterations in iNOS protein
content, whereas coronal tissue sections were analyzed for iNOS subcellular distribution. (A) Immunoreactive bands of iNOS and actin, and quantitative iNOS protein content. Results are
expressed as the ratio of iNOS to that of actinbands andpresented asmean values (±SD; n=4). *Statistically significant (pb0.01) comparedwith controls. iNOS (rabbit IgG, 1:1000, Abcam
ab3523) was used as primary antibody. (B) Double immunohistochemistry of iNOS protein and neuronal marker neurofilament (NF) in frontal cortex. iNOS (red) colocalized with NF
(green) and DAPI (blue) in control (a, b), EtOH (c, d), and EtOH+ALC (e, f). iNOS (rabbit IgG, 1:50, Abcam ab3523) and NF (mouse IgG, 1:100, Abcam ab28029) were used as primary
antibodies. Alexa Fluor 488 anti-mouse for neurofilaments and Alexa Fluor 594 anti-rabbit for iNOS were used as secondary antibodies. Original magnification, ×20.
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that iNOS was indeed perfectly colocalized with NeuN, as shown in
Figs. 4A–I. Interestingly, we observed fewer neurons in brain tissues
from the EtOH condition compared with the control or the ALC+ EtOH
condition (Figs. 4E and F).
We then examined the levels of 3-nitrotyrosine protein adducts
(3-NT immunoreactivity is a signature of peroxynitrite binding to
proteins). We examined their subcellular localization in frontal
cortex. Antibody to 3-NT detected three immunoreactive proteins
with band sizes of 25, 55, and 160 kDa. Because the immunoreactive
bands for 25 and 160 kDa were very weak (bands were not accurately
quantifiable after minimizing background), we present the data
obtained from the 55-kDa immunoreactive protein band. We found
that ethanol administration caused a 2.3-fold increase in the 3-NT
protein level, which paralleled a significant induction of 3-NT protein
staining that was, again, distinctly colocalized with the neuronal
marker NeuN, suggesting that 3-nitrotyrosine protein adducts were
formed because of iNOS induction (Figs. 5A and B). Unlike CoQ10,
administration of ALC significantly blocked the ethanol-elicited up-
regulation of 3-NT protein to levels that approached those of controls.
These results confirm our recent findings that EtOH/Ach caused a 45%
induction of iNOS protein level in primary human neurons [17]. As a
positive control for 3-NT formation, brain tissue slices from control
animals were incubated (1 h in CO2 incubator) with an authentic
peroxynitrite-generating compound, 3-morpholinosydnonimine hy-
drochloride (SIN-1; 300 μM), in the absence and presence of
equimolar uric acid, a peroxynitrite scavenger. For the presence of
uric acid condition, tissue slices were exposed to uric acid for 20 min
in a CO2 incubator before the addition of SIN-1 and uric acid was
present at the time of SIN-1 treatment. As anticipated, the increased
level of 3-NT protein expression after SIN-1 treatment was prevented
by coadministration of uric acid (Fig. 5C).
Because iNOS induction and 3-NT formation led to neuroinflam-
mation, we also studied the localization of 3-NT protein in astrocytes
and microglia in brain tissue from ethanol-fed, their pair-fed controls,
and alcohol + ALC-fed mice. Interestingly, 3-NT was weakly
colocalized with the astrocytic marker protein GFAP (Figs. 6A–D),
but was not detected in microglia (data not shown), suggesting that
alcohol intake up-regulated iNOS mostly in neurons. However,
numbers of distinctly stained microglia were higher in brain tissue
from alcohol-fed animals (46 cells/μm2) than in pair-fed control mice
(10 cells/μm2) in the same brain region (Figs. 6E and F), suggesting
the development of an inflammatory process as a result of
microgliosis in ethanol-fed mice.
Because iNOS induction did not seem to be a prominent source of
oxidative stress in astrocytes and microglia, we examined the
localization of NOX1 protein with the astrocyte marker protein
GFAP and the microglia marker protein Iba1 in the frontal cortex.
Immunohistochemical detection revealed an association between
NOX1 activation and astroglial activation in alcohol-fed mice as
evidenced by the colocalization of NOX1 protein with GFAP (Fig. 7)
and Iba1 (Fig. 8). Again, ALC treatment partially neutralized the effects
of alcohol on NOX1 protein expression in astrocytes and microglia.
Fig. 4. Induction of iNOS in the brain perfectly colocalizes with NeuN in neuronal cell bodies. Immunofluorescence histochemical stainings of iNOS (red), NeuN (green), and DAPI
nuclei (blue) in brain tissue sections. (A–C) Control brain tissue, (D–F) alcohol brain tissue, and (G–I) coadministration of alcohol and ALC in brain tissues. iNOS (rabbit IgG, 1:50,
Abcam ab3523) and NeuN (mouse IgG, 1:250, Abcam ab77315) were used as primary antibodies. Alexa Fluor 488 anti-mouse for NeuN and Alexa Fluor 594 anti-rabbit for iNOS were
used as secondary antibodies. Original magnification, ×20.
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To assess the association between NOX1 activation and oxidative
damage in the brain, we then evaluated the changes in NOX1 protein
level and formation of the ROS-mediated lipid peroxidation product
4-HNE. Antibody to NOX1 detected multiple immunoreactive bands
with a prominent band size of approximately 65 kDa, which was the
expected molecular weight of NOX1 protein. Ethanol administration
caused a 2.5-fold increase in the intensity of the 65-kDa NOX1-
immunoreactive band in brain tissues compared with brains from
pair-fed controls (Fig. 9A). Elevation in NOX1 protein level was
accompanied by a 2.8-fold increase in 4-HNE protein adduct content
in alcohol-fed mice compared with controls (Fig. 9B). Coadministra-
tion of ALC (but not malonyl coenzyme A or CoQ10) almost
completely abrogated the up-regulation by alcohol of NOX1 and 4-
HNE protein in the brain. To verify the formation of 4-HNE (a
signature of ROS oxidatively damaged proteins), we measured ROS
production by a direct electron paramagnetic resonance method in
this brain region. These analyses confirmed our findings with 4-HNE
that chronic alcohol ingestion significantly enhanced the production
of ROS, and, interestingly, ALC diminished ROS generation (Fig. 9C).
Thus, our findings indicate that ALC neutralizes oxidative damage in
the brain caused by chronic ethanol administration.
Discussion
In previous studies, we found that the mortality of mice (C57BL/
6J) increased at week 4 or 5 when the ethanol concentration in the
liquid diet was higher than 4% (vol/vol). Thus, in this study, we
avoided suchmortality by feedingmice ethanol as 28% of total calories
(4% wt/vol) in the liquid diet for 8 weeks. This concentration is
considered a high ethanol dose in mice. Blood alcohol levels were
10.6–17.6 mM (0.05–0.1%). Although brain alcohol level was not
determined in this study, we surmise a range similar to that of the
blood level because ethanol easily crosses the blood–brain barrier.
This was demonstrated by the report of Griffin et al. [25] in which a
blood alcohol level of 27.7–36.4 mM was similar to the brain alcohol
level of 28.4–35.4 mM in mice after either voluntary drinking or
exposure to ethanol vapor. Despite the modest body weight gain, the
loss of brain tissue weight in the alcohol groups was attributed to
Fig. 5. Induction of iNOS correlates with increased 3-nitrotyrosine protein adduct levels in frontal cortical neurons. Protein extracts were examined for changes in 3-NT protein
content, whereas tissue sections were used for 3-NT subcellular localization. (A) 3-NT protein adducts (detected by 3-nitrotyrosine antibody) colocalized with NeuN (neuronal
antibody). Fluorescent stain for NeuN protein (green), 3-NT protein (red), and DAPI (blue) is shown in control (a, b), EtOH (c, d), and EtOH + ALC (e, f). 3-NT (rabbit IgG, 1:200,
Abcam ab78406) and NeuN (mouse IgG, 1:250, Abcam ab77315) were used as primary antibodies. Alexa Fluor 488 anti-mouse for NeuN and Alexa Fluor 594 anti-rabbit for 3-NT
were used as secondary antibodies. Original magnification, ×20. (B) Immunoreactive bands of 3-NT and actin, and quantitative 3-NT protein content. Results are expressed as the
ratio of 3-NT protein adduct to actin bands and presented as mean values (±SD; n=4). *Statistically significant (pb0.01) compared with control. (C) Immunoreactive bands of 3-
NT-protein adduct and actin in SIN-1-treated brain tissue samples and quantitative 3-NT protein content. Results are expressed as the ratio of 3-NT to actin bands and presented as
mean values (±SD; n=3). 3-NT (mouse IgG, 1:1000, Abcam ab52309) was used as primary antibody. **Statistically significant (pb0.01) compared with control.
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brain shrinkage due to loss of white and gray matter, which has been
documented in chronic alcohol abusers [26,27].
The significance of the present findings is that chronic alcohol
feeding activated ROS- and RNS-generating pathways in specific brain
cell types. The induction of oxidative damage and activation of
inflammatory response in these different cell types abrogated the loss
of neurons and long-term potentiation of synaptic neurotransmission
in the frontal cortex. We noted that timely administration of ALC
significantly stabilized the long-term synaptic neurotransmission of
dopaminergic and cholinergic neurons by preventing the activation of
iNOS, NOX, and glial cells.
It was anticipated that an increase in iNOS protein would correlate
with an up-regulation of 3-nitrotyrosine protein levels in the frontal
cortex of ethanol-fed mice. Colocalization of neurofilaments and iNOS
protein confirmed that iNOS was mostly expressed in neurons around
a single or a couple of nuclear membranes. Detection of iNOS (NOS2)
protein in the pair-fed controls may be due to cross-reaction of iNOS
antibody with the constitutive nNOS (NOS1) protein, which was
apparent by the similar nuclearmembrane staining pattern of nNOS in
brain tissue sections (data not shown). Remarkably, neither astro-
cytes normicroglia exhibited colocalization of iNOS/3-NT in this brain
region, further confirming not only that iNOS induction is a major
source of peroxynitrite, but also that the enzyme is not responsive in
astrocytes and microglia. These findings indicate that chronic alcohol
ingestion preferentially modulates iNOS protein level in neurons but
not in astrocytes or microglia, validating our recent findings that
EtOH/Ach exposure increased the level of iNOS protein in cultured
primary human neurons [17]. Apart from these findings, Konovko et
al. [28] reported an induction of iNOS in cerebellar cortical neurons;
however, induction of iNOS in cerebral neurons by chronic alcohol
consumption had been only rarely documented in the literature. We
conclude that iNOS induction led to accumulation of NO and
peroxynitrite formation thereby promoting the transduction of
oxidative stress and neuronal degeneration during chronic ethanol
consumption.
Although we observed that ethanol-elicited iNOS induction was
specific to neurons, the increase in NOX level, which produces ROS,
and 4-HNE formation correlated with a colocalization of NOX protein,
which was specific to astrocytes and microglia. Nitric oxide freely
diffuses across biological membranes, whereas endogenously formed
ROS (superoxide and hydroxyl radicals) do not cross the cell
membrane. This implies that NO generated by neurons diffuses into
Fig. 6.Detection of nitrotyrosine immunoreactivity in frontal cortical astrocytes. (A–D) Brain frontal tissue sections were stained for 3-NT protein adducts (red) andmerged with the
astrocyte-specific protein marker GFAP (green). (A) 3-NT in control tissue, (B) 3-NT in alcoholic tissue, (C) colocalization of 3-NT and GFAP proteins in control, (D) colocalization of
3-NT and GFAP proteins in brains of alcohol-fedmice. 3-NT (mouse IgG, 1:200, Abcam ab61392) and GFAP (rabbit IgG, 1:250, Abcam ab7260) were used as primary antibodies. Alexa
Fluor 488 anti-rabbit for GFAP and Alexa Fluor 594 anti-mouse for 3-NT were used as secondary antibodies. (E, F) The brain frontal tissue sections from control and alcohol -fed mice
were stained for the microglia marker Iba1 (green). (E) Iba1 in control tissue, (F) Iba1 in alcoholic tissue. Goat IgG Iba1 (1:100, Abcam ab5076) was used as primary antibody. Alexa
Fluor 488 anti-goat was used for Iba1 as secondary antibody. Original magnification, ×20.
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glial cells and reacts with superoxide to form highly reactive
peroxynitrite. This would cause oxidative stress and an inflammatory
response in glial cells as indicated by gliosis after alcohol abuse. In
neuronal cells, excess production of NO is expected to shift the
chemistry into pronitrosative conditions. However, leakage of ROS
from neuronal mitochondria may favor the formation of peroxynitrite
within neurons. Formation of peroxynitrite either in glial cells or in
neurons can then exacerbate physiological damage as observed in
alcohol-exposed brain endothelial cells [17,29] or in livers of ethanol-
fed rodents [30]. Most importantly, ALC significantly minimized the
level of alcohol-induced iNOS/nitrotyrosine adduct formation in
neurons and further prevented NOX protein induction in astrocytes
and microglia, thereby preventing gliosis in the frontal cortex. These
findings indicated that ALC, by providing carnitine and acetyl groups,
Fig. 7. NOX1 protein colocalized with astrocytes (GFAP) in the frontal cortex. Double immunohistochemistry of GFAP (green) with NOX1 (red) protein (A, B) in control brain tissue,
(C, D) in alcohol brain tissue, and (E, F) in coadministration of alcohol and ALC brain tissues. NOX1 (rabbit IgG, 1:150, Abcam ab55831) and GFAP (mouse IgG, 1:250, Abcam ab10062)
were used as primary antibodies. Alexa Fluor 488 anti-mouse for GFAP and Alexa Fluor 594 anti-rabbit for NOX1were used as secondary antibodies. Original magnification, ×20.
Fig. 8. Brain frontal cortex tissue sections from chronic studies were stained for colocalization of NOX1 (red) protein with microglia (Iba1; green). (A) Control, (C) EtOH, and (E) EtOH+
ALC;NOX1alone. (B)Control, (D) EtOH, and (F) EtOH+ALC, colocalizationofNOX1withmicroglia.Microgliawere immunolabeledwith antibody to Iba1 (goat IgG, 1:100) orNOX1(rabbit
IgG, 1:200) for 1 h at 24 °C. NOX1 (rabbit IgG, 1:150, Abcam ab55831) and Iba1 (goat IgG, 1:100, Abcam ab5076) were used as primary antibodies. Alexa Fluor 488 anti-goat for Iba1 and
Alexa Fluor 594 anti-rabbit for NOX1 were used as secondary antibodies. Original magnification, ×20.
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has therapeutic value as an antioxidant and anti-inflammatory agent.
However, ALC is not a direct scavenger of free radicals (ROS or RNS).
Thus, we postulate that ALC exerts its antioxidant property by indirect
mechanisms such as its ability to maintain mitochondrial membrane
potential transition. One possible mechanism by which ALC could act
is by suppressing the activation of free radical-generating pathways
such as iNOS and NOX as indicated by the present findings. The
molecular mechanism of suppressing iNOS and NOX activation by ALC
in the CNS warrants further investigation. Another plausible mech-
anism for ALC to circumvent the excessive level of oxidative stress is
to stabilize the naturally occurring biological antioxidant enzymes
and antioxidants such as SOD, catalase, or the intracellular levels of
glutathione. In fact, Mansour [31] reported that a high dose (250 mg/
kg body wt) of ALC significantly increase glutathione peroxidase and
SOD activities in the lungs and livers of rodents, and Calabrese et al.
[32] demonstrated the induction of heme oxygenase-1, Hsp70, and
SOD-2 by ALC, suggesting that ALC can act as an antioxidant by
inducing these antioxidant enzymes. It is now widely accepted that
oxidative damage and inflammation contribute to white and gray
matter injury in the brain [33]. Thus, minimizing oxidative damage
could alleviate the inflammatory response because oxidative stress
has been linked to initiation of neuroinflammation [10]. Such was the
case in this study, that the numbers of microglia in alcoholic brain
were higher than those in mice given ALC plus alcohol or in the pair-
fed controls. Whether ALC prevented the infiltration of leukocytes
into the brain or maturation and homing of microglia in the CNS
remains to be investigated. These studies established the link between
oxidative stress and inflammatory response in specific cell types in the
brain during chronic alcohol ingestion, validating our recent findings
that ethanolmetabolism causes a significant induction of iNOS protein
level in primary human neurons [17].
An equally important findingwas the stabilization of the LFS and LTP
synaptic transmission by ALC in the frontal cortex after chronic alcohol
ingestion. Itmust be noted here that these data demonstrated the actual
physiological decaying pattern of neuronal transmission in chronic
alcohol consumption without any stimulating or antagonizing agent at
the time of electrophysiological recording. Under this ex vivo condition
without agonist or antagonist, the LTP transmission of all experimental
conditions was expected to overlapwith time to the basal level because
of a decrease in neuronal viability. Although the neurotransmission of
ALC + EtOH decayed faster than that of the pair-fed control, the
protective effect of ALC from chronic alcohol abuse was visible and
statistically significant for the first 30-min time point. This finding
suggested that, althoughALCprovidedneuroprotection, itwasunable to
inhibit the sensitivity to chronic alcohol insult completely.
Because synaptic transmission is a highly energy-dependent
process, stabilization of neurotransmission by ALC after long-term
alcohol consumption may be associated with protection of neuronal
mitochondrial function. In particular, the ability of ALC to prevent
alcohol-induced mitochondrial damage, energy depletion due to
defective respiratory chain complexes, oxidative-mediated neuroin-
flammation, and neuronal degeneration will be of significant
importance in further investigations. Indeed, during chronic alcohol
consumption, ALC sustained the neuronal LFS and LTP synaptic
transmission by preserving the integrity of neurofilaments and by
maintaining dopaminergic and cholinergic neurons. These findings
lead us to suggest that ALC regulates the activation of the
acetylcholine receptor, as the acetyl group is an essential precursor
for the neurotransmitter acetylcholine. Because alcohol is a legalized
substance of abuse and there are few pharmacological treatments for
alcohol-induced brain injury, we propose that daily use of dietary ALC
(1–2 mg/kg body wt) by alcohol abusers could provide a potential
health benefit. The significance of this proposal originated from the
fact that ALC is already in clinical use as a therapeutic agent for
treatment of neurological diseases.
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